Delivery Order SPE2DR25D9354-SPE2DR26FQLM4
Award Date 12/12/25
Potential Completion Date 1/6/26
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. for 34 mg Nuplazid capsules (30-count units) on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a single line item fulfillment under DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,586.94 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 10 mg tablets (30-count) with an ultimate completion date of January 5, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $10,588.89 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units) with an ultimate completion date of December 2, 2025. This delivery order, issued on November 7, 2025, operates under a firm fixed-price contract structure with no set-aside designation, allowing the contract to compete in the unrestricted federal procurement marketplace. DMS Pharmaceutical Group Inc., a woman-owned small...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,373.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nuplazid 10 mg tablets (30-count packages). The award, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries a firm fixed-price contract type with no set-aside designation, indicating the vendor competed in unrestricted federal...
- The Defense Logistics Agency awarded a $21,177.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in quantities of 30. The delivery order, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group was...
- The Defense Logistics Agency awarded a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The delivery order, issued on November 12, 2025, with completion scheduled by December 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of Nuplazid 34 mg capsules in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a continuation of the ongoing pharmaceutical supply relationship between DLA and the Park Ridge, Illinois-based vendor. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Nuplazid (pimavanserin) 34 mg capsules in quantities of 30 units. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this delivery order under a firm fixed-price contract with a ceiling value of $10,375.53. The order represents no set-aside designation and carries an ultimate completion date...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 20, 2025. The contract covers the supply of Nuplazid 34 mg capsules in quantities of 30, with a firm fixed-price structure and an ultimate completion date of September 11, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an...